Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Angstwurm

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Critical Care Medicine|November 9, 2005
Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!M Angstwurm
Der Internist|February 17, 2022
[32/f-Hip and back pain : Preparation for the medical specialist examination: part 146]M Angstwurm
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Significance of selenium in intensive care medicine. Clinical studies of patients with SIRS/sepsis syndrome]R Gärtner, M Angstwurm
MMW Fortschritte Der Medizin|May 31, 2008
[Antibiotic therapy in the family doctor's office]J R Bogner, M Angstwurm
Der Internist|December 6, 2001
[Spectrum of diagnoses in an internal medicine emergency unit]C Burchardi, M Angstwurm, S Endres
Resuscitation|March 27, 2013
NSE and S-100B are not sufficiently predictive of neurologic outcome after therapeutic hypothermia for cardiac arrestT Zellner, R Gärtner, J Schopohl, et al.
Infection|July 8, 2000
Drug resistance in intensive care unitsW C Albrich, M Angstwurm, L Bader, et al.
Der Anaesthesist|February 4, 2009
[Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin]M Angstwurm, J Hoffmann, H Ostermann, et al.
Clinical and Experimental Immunology|July 2, 1998
Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapyG Fingerle-Rowson, M Angstwurm, R Andreesen, et al.
Lancet (London, England)|March 9, 1996
Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastasesK Pantel, J Izbicki, B Passlick, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Critical Care Medicine|November 9, 2005
Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!M Angstwurm
Der Internist|February 17, 2022
[32/f-Hip and back pain : Preparation for the medical specialist examination: part 146]M Angstwurm
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Significance of selenium in intensive care medicine. Clinical studies of patients with SIRS/sepsis syndrome]R Gärtner, M Angstwurm
MMW Fortschritte Der Medizin|May 31, 2008
[Antibiotic therapy in the family doctor's office]J R Bogner, M Angstwurm
Der Internist|December 6, 2001
[Spectrum of diagnoses in an internal medicine emergency unit]C Burchardi, M Angstwurm, S Endres
Resuscitation|March 27, 2013
NSE and S-100B are not sufficiently predictive of neurologic outcome after therapeutic hypothermia for cardiac arrestT Zellner, R Gärtner, J Schopohl, et al.
Infection|July 8, 2000
Drug resistance in intensive care unitsW C Albrich, M Angstwurm, L Bader, et al.
Der Anaesthesist|February 4, 2009
[Severe sepsis and disseminated intravascular coagulation. Supplementation with antithrombin]M Angstwurm, J Hoffmann, H Ostermann, et al.
Clinical and Experimental Immunology|July 2, 1998
Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapyG Fingerle-Rowson, M Angstwurm, R Andreesen, et al.
Lancet (London, England)|March 9, 1996
Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastasesK Pantel, J Izbicki, B Passlick, et al.
Pageof 2